Edoxaban
Pre-clinicalCompleted 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Venous Thromboembolism
Conditions
Venous Thromboembolism
Trial Timeline
Mar 27, 2017 → Oct 29, 2019
NCT ID
NCT02952599About Edoxaban
Edoxaban is a pre-clinical stage product being developed by Daiichi Sankyo for Venous Thromboembolism. The current trial status is completed. This product is registered under clinical trial identifier NCT02952599. Target conditions include Venous Thromboembolism.
What happened to similar drugs?
6 of 20 similar drugs in Venous Thromboembolism were approved
Approved (6) Terminated (2) Active (13)
Hype Score Breakdown
Clinical
3
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (14)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05804747 | Pre-clinical | Completed |
| NCT04747496 | Pre-clinical | Completed |
| NCT04594915 | Pre-clinical | Completed |
| NCT04519944 | Pre-clinical | Completed |
| NCT04171726 | Phase 3 | UNKNOWN |
| NCT03840291 | Approved | Completed |
| NCT03247569 | Pre-clinical | Completed |
| NCT03247582 | Pre-clinical | Completed |
| NCT02952599 | Pre-clinical | Completed |
| NCT02951039 | Pre-clinical | Completed |
| NCT02964949 | Pre-clinical | Completed |
| NCT02943993 | Pre-clinical | Completed |
| NCT02944019 | Pre-clinical | Completed |
| NCT02448901 | Pre-clinical | UNKNOWN |
Competing Products
20 competing products in Venous Thromboembolism